Cilostazol and Hepatitis aggravated - a phase IV clinical study of FDA data

Summary:

Hepatitis aggravated is reported as a side effect among people who take Cilostazol (cilostazol), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Aspirin, and have Primary pulmonary hypertension.

The phase IV clinical study analyzes which people have Hepatitis aggravated when taking Cilostazol. It is created by eHealthMe based on reports of 7,796 people who have side effects when taking Cilostazol from the FDA, and is updated regularly.

What is Cilostazol?

Cilostazol has active ingredients of cilostazol. It is often used in arteriosclerosis of the extremities. eHealthMe is studying from 7,877 Cilostazol users. Check the latest studies of Cilostazol.

What is Hepatitis aggravated?

Hepatitis aggravated is found to be associated with 1,141 drugs and 433 conditions by eHealthMe. Check the latest studies of Hepatitis aggravated.

On Jul, 08, 2026

7,796 people reported to have side effects when taking Cilostazol.
Among them, 23 people (0.3%) have Hepatitis aggravated.

Could Cilostazol cause Hepatitis aggravated?

Among these 23 people:

How long have people been on Cilostazol when they have Hepatitis aggravated? *

What is the gender of people who have Hepatitis aggravated when taking Cilostazol? *

female: 26.09 %
male: 73.91 %

What is the age of people who have Hepatitis aggravated when taking Cilostazol? *

What are other drugs people take besides Cilostazol? *

Aspirin: 7 people, 30.43%
Clopidogrel: 6 people, 26.09%
Warfarin Sodium: 5 people, 21.74%
Allopurinol: 5 people, 21.74%
Tamsulosin Hydrochloride: 4 people, 17.39%
Magnesium Oxide: 4 people, 17.39%
Lansoprazole: 4 people, 17.39%
Bisoprolol Fumarate: 3 people, 13.04%
Tiotropium Bromide: 3 people, 13.04%
Tracleer: 3 people, 13.04%

What are other side effects people have besides Hepatitis aggravated? *

Blood Bilirubin Increased: 5 people, 21.74%
Liver Function Tests Nos Abnormal: 4 people, 17.39%
Aspartate Aminotransferase Increased: 4 people, 17.39%
Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight): 3 people, 13.04%
Blood Alkaline Phosphatase Increased: 3 people, 13.04%
Pneumonia: 3 people, 13.04%
Fever: 3 people, 13.04%
Alanine Aminotransferase Increased: 3 people, 13.04%
Acute Myocardial Infarction (acute heart attack): 3 people, 13.04%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 8.70%

What are the existing conditions these people have? *

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 5 people, 21.74%
Neuropathy Peripheral (surface nerve damage): 3 people, 13.04%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 2 people, 8.70%
Non-Small Cell Lung Cancer Stage Iv: 2 people, 8.70%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 8.70%
Malignant Melanoma Stage Iv (the cancer has spread to other places in the body, such as the lung, liver, brain, bone, soft tissue, or gastrointestinal (gi) tract. cancer may have spread to places in the skin far away from where it first started): 2 people, 8.70%
High Blood Pressure: 2 people, 8.70%
Gastric Ulcer (stomach ulcer): 2 people, 8.70%
Enlarged Prostate: 2 people, 8.70%
Dyslipidaemia (abnormal amount of lipids): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Cilostazol and have Hepatitis aggravated?

- Check whether Hepatitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cilostazol:

Cilostazol (7,877 reports)

Browse all side effects of Cilostazol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis aggravated:

Hepatitis aggravated (1,142 drugs)

Browse all the conditions that are associated with Hepatitis aggravated:

Hepatitis aggravated (433 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cilostazol (the active ingredients of Cilostazol) and Cilostazol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.